bpc-157 half-life metabolism Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review BPC 157 Dosage: A Doctor's

Target dose (mg or mcg)

Sci., 2018 Sikiric et al., BPC 157 and Stable Gastric Pentadecapeptide, Pharmaceuticals, 2024 Lee et al., MOTS-c: mitochondrial-derived peptide, Cell Metabolism, 2015 Brunel University London Epitalon replication study, 2025

The History & Origins BPC-157 was first characterized in the 1990s by researchers led by Predrag Sikiric at the University of Zagreb in Croatia

Studies are also investigating the long-term benefits and cumulative effects of sustained peptide use

Madaio was corresponding author of a study this summer also in Kidney International that showed that using the same antibody, this time to deliver the anti-inflammatory protein kinase C-alpha inhibitor directly to the kidney, enabled the organs recovery in a similar model of nephritis